Vonoprazan Fumarate | USP/EP-Certified Bulk API for Acid Reflux & Ulcer Treatment?

?? ?Product Overview?

Vonoprazan Fumarate (TAK-438), a next-generation ?potassium-competitive acid blocker (P-CAB)?, is engineered for superior gastric acid suppression in ?GERD (gastroesophageal reflux disease)? and ?peptic ulcer therapy??12. With high bioavailability and rapid action, it outperforms traditional PPIs in pH control and treatment adherence?34.

?? ?Key Features?

• ?Regulatory Compliance?

  : Meets 

  ?USP/EP pharmacopeial standards?

   with ≥99% HPLC purity for API manufacturing?14.

• ?Enhanced Stability?

  : 36-month shelf life under controlled storage (15-25°C, dry environment)?45.

• ?Mechanistic Advantage?

  : Irreversible binding to H+/K+-ATPase pumps ensures prolonged acid suppression?23.

?? ?Applications?

• ?Pharmaceutical Formulations?

  : Core API in 

  ?GERD medications?

  , 

  ?H. pylori eradication regimens?

  , and 

  ?NSAID-induced ulcer prophylaxis?

  ?13.

• ?Research Use?

  : Critical for 

  ?gastrointestinal pharmacology studies?

   and 

  ?acid-related disorder drug development?

  ?26.

?? ?Quality Assurance?

• ?Batch Traceability?

  : Provided with COA, MSDS, and ICH-compliant impurity profiles (total impurities <0.5%)?45.

• ?Packaging?

  : Available in 

  ?1kg vacuum-sealed foil bags?

   and 

  ?25kg fiber drums?

   with nitrogen protection?56.

??? Google Keywords?:

• Bulk USP-Grade Vonoprazan Fumarate Supplier

• TAK-438 API for GERD Treatment

• High-Purity P-CAB Inhibitor Raw Material

• Pharmaceutical-Grade Acid Reflux API?13